Cargando…
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
Background: Nanoparticles are under investigation as carrier systems for anticancer drugs. The expression of efflux transporters such as the ATP-binding cassette (ABC) transporter ABCB1 is an important resistance mechanism in therapy-refractory cancer cells. Drug encapsulation into nanoparticles has...
Autores principales: | Pieper, Sebastian, Onafuye, Hannah, Mulac, Dennis, Cinatl, Jindrich, Wass, Mark N, Michaelis, Martin, Langer, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839550/ https://www.ncbi.nlm.nih.gov/pubmed/31728254 http://dx.doi.org/10.3762/bjnano.10.201 |
Ejemplares similares
-
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
por: Onafuye, Hannah, et al.
Publicado: (2019) -
Drug-adapted cancer cell lines as preclinical models of acquired resistance
por: Michaelis, Martin, et al.
Publicado: (2019) -
Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy
por: Ward, Jane L., et al.
Publicado: (2020) -
Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles
por: Partikel, Katrin, et al.
Publicado: (2019) -
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
por: Bojkova, Denisa, et al.
Publicado: (2022)